Squarepoint Ops LLC Eq Rx, Inc. Transaction History

Squarepoint Ops LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$1.8 - $2.83 $53,766 - $84,532	29,870 New	29,870 $57,000
Q3 2022 Nov 14, 2022	BUY	$0.94 - $5.99 $52,333 - $333,487	55,674 New	55,674 $276,000
Q2 2022 Aug 15, 2022	SELL	$3.2 - $5.69 $1.35 Million - $2.41 Million	-423,159 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$2.8 - $7.39 $1.18 Million - $3.13 Million	423,159 New	423,159 $1.75 Million

67.8M

Ticker EQRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 448,140,992
Description
EQRx, Inc., a pharmaceutical company, engages in developing medicines primarily for the treatment of oncology and immune-inflammatory diseases in the United States. The company's pre-registrational programs in Phase III clinical trial include Aumolertinib, an epidermal growth factor receptor (EGFR) inhibitor for the treatment of patients with EG...

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

Stay updated on Squarepoint Ops LLC with notifications on news.